Last reviewed · How we verify

bLAC

NatImmune A/S · FDA-approved active Small molecule Quality 0/100

At a glance

Generic namebLAC
SponsorNatImmune A/S
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results